Effect of in vitro exposure to hay dust on the gene expression of chemokines and cell-surface receptors in primary bronchial epithelial cell cultures established from horses with chronic recurrent airway obstruction

American Journal of Veterinary Research

Volumn 70, Issue 3, 2009, Pages 365-372

  Ainsworth, Dorothy M ^a   Matychak, MaryBeth ^a   Reyner, Claudia L ^b   Erb, Hollis N ^a   Young, Jean C ^a  

^a Department of Obstetrics Gynecology   (United States)

^b Plant Breeding and Genetics Section in the School of Integrative Plant Science   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCAN; CELL SURFACE RECEPTOR; CHEMOKINE; CXCL2 CHEMOKINE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERLEUKIN 1 RECEPTOR TYPE I; INTERLEUKIN 1BETA; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ARTICLE; BRONCHUS MUCOSA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DOWN REGULATION; DUST EXPOSURE; FEMALE; GENE EXPRESSION PROFILING; HORSE DISEASE; IN VITRO STUDY; MALE; NEUTROPHILIA; NONHUMAN; NUCLEOTIDE SEQUENCE; UPREGULATION; ANIMAL; ANIMAL DISEASE; ANIMAL FOOD; BRONCHUS; CELL CULTURE; CYTOLOGY; DUST; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; HORSE; IMMUNOLOGY; METABOLISM;

EQUIDAE;

ANIMAL FEED; ANIMALS; BRONCHI; CELLS, CULTURED; CHEMOKINES; DUST; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; HORSE DISEASES; HORSES; LIPOPOLYSACCHARIDES; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, CELL SURFACE;

EID: 63249110290     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.70.3.365     Document Type: Article

References (38)

1. Takizawa H. Bronchial epithelial cells in allergic reactions. Curr Drug Targets Inflamm Allergy 2005;4:305-311.
2. Fuke S, Betsuyaku T, Nasuhara Y, et al. Chemokines in bronchiolar epithelium in the development of chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2004;31:405-412.
3. Qiu Y, Zhu J, Bandi V, et al. Bronchial mucosal inflammation and upregulation of CXC chemoattractants and receptors in severe exacerbations of asthma. Thorax 2007;62:475-482.
4. Barnes PJ, Chowdhury B, Kharitonov SA, et al. Pulmonary biomarkers in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;174:6-14.
5. Ying S, Meng Q, Zeibecoglou K, et al. Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoatttractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (intrinsic) asthmatics. J Immunol 1999;163:6321-6329.
6. Schutz C, Wolf K, Harth M, et al. Expression and release of interleukin-8 by human bronchial epithelial cells from patients with chronic obstructive pulmonary disease, smokers, and never-smokers. Respiration 2003;70:254-261.
7. Hamilton LM, Torres-Lozano C, Puddicombe SM, et al. The role of the epidermal growth factor receptor in sustaining neutrophil inflammation in severe asthma. Clin Exp Allergy 2003;33:233-240.
8. MacRedmond RE, Greene CM, Dorscheid DR, et al. Epithelial expression of TLR4 is modulated in COPD and by steroids, salmeterol and cigarette smoke. Respir Res 2007;8:84-96.
9. Bureau F, Bonizzi G, Kirschvink N, et al. Correlation between nuclear factor-κB activity in bronchial brushing samples and lung dysfunction in an animal model of asthma. Am J Respir Crit Care Med 2000;161:1314-1321.
10. Couëtil LL, Art T, deMoffarts B, et al. Effect of beclomethasone dipropionate and dexamethasone isonicotinate on lung function, bronchoalveolar lavage fluid cytology, and transcription factor expression in airways of horses with recurrent airway obstruction. J Vet Intern Med 2006;20:399-406.
11. Ainsworth DM, Wagner B, Franchini M, et al. Time-dependent alterations in gene expression of interleukin-8 in the bronchial epithelium of horses with recurrent air-way obstruction. Am J Vet Res 2006;67:669-677.
12. Berndt A, Derksen FJ, Venta PJ, et al. Elevated amount of Toll-like receptor 4 mRNA in bronchial epithelial cells is associated with air-way inflammation in horses with recurrent airway obstruction. Am J Physiol Lung Cell Mol Physiol 2007;292:L936-L943.
13. DeLuca L, Erb HN, Young JC, et al. The effect of adding oral dexamethasone to feed alterations on the airway cell inflammatory gene expression in stabled horses affected with recurrent airway obstruction. J Vet Intern Med 2008;22:427-435.
14. Mambula SS, Sau K, Henneke P, et al. Toll-like receptor (TLR) signaling in response to Aspergillus fumigatus. J Biol Chem 2002;277:39320-39326.
15. Chase MA, Wheeler DS, Lierl KM, et al. Hsp 72 induces inflammation and regulates cytokine production in airway epithelium through a TLR4- and NF-κB-dependent mechanism. J Immunol 2007;179:6318-6324.
16. Brass DM, Hollingsworth JW, Fessler MB, et al. The IL-1 type 1 receptor is required for the development of LPS-induced airways disease. J Allergy Clin Immunol 2007;120:121-127.
17. Ainsworth DM, Grünig G, Matychak MB, et al. Recurrent airway obstruction (RAO) in horses is characterized by IFN-γ and IL-8 production in bronchoalveolar lavage cells. Vet Immunol Immunopathol 2003;96:83-91.
18. Robinson NE. International Workshop on Equine Chronic Airway Disease. Michigan State University 16-18 June 2000. Equine Vet J 2001;33:5-19.
19. Pirie RS, McLachlan G, McGorum BC. Evaluation of nebulised hay dust suspensions (HDS) for the diagnosis and investigation of heaves. 1: preparation and composition of HDS. Equine Vet J 2002;34:332-336.
20. Ainsworth DM, Wagner B, Erb HN, et al. Effects of in vitro exposure to hay dust on expression of interleukin-17, -23, -8, and -b and chemokine (C-X-C motif) ligand 2 by pulmonary mononuclear cells isolated from horses chronically affected with recurrent airway disease. Am J Vet Res 2007;68:1361-1369.
21. User bulletin#2 ABI Prism 7700 Sequence Detection System. Foster City, Calif: PE Applied Biosystems, 1997.
22. Lin C, Holland RE Jr, Williams NM, et al. Cultures of equine respiratory epithelial cells and organ explants as tools for the study of equine influenza virus infection. Arch Virol 2001;146:2239-2247.
23. Fairbairn SM, Page CP, Lees P et al. Early neutrophil but not eosinophil or platelet recruitment to the lungs of allergic horses following antigen exposure. Clin Exp Allergy 1993;23:821-828.
24. Chung KF. Cytokines as targets in chronic obstructive pulmonary disease. Curr Drug Targets 2006;7:675-681.
25. Kobayashi Y. The role of chemokines in neutrophil biology. Front Biosci 2008;13:2400-2407.
26. Fulkerson PC, Zimmerman N, Hassman LM, et al. Pulmonary chemokine expression is coordinately regulated by STAT1, STAT6, and IFN-γ. J Immunol 2004;173:7565-7574.
27. Xu WB, Haddd EB, Tsukagoshi H, et al. Induction of macrophage inflammatory protein 2 gene expression by interleukin-1β in rat lung. Thorax 1995;50:1136-1140.
28. Riihimäki M, Raine A, Pourazar J, et al. Epithelial expression of mRNA and protein for IL-6, IL-10 and TNF-α in endobronchial biopsies in horses with recurrent airway obstruction. BMC Vet Res [serial online]. 2008;4:8. Available at: www.biomedcentral.com/1746-6148/ 4/8. Accessed May 8, 2008.
29. Riihimäki M, Raine A, Art T, et al. Partial divergence of cytokine mRNA expression in bronchial tissues compared to bronchoalveolar lavage cells in horses with recurrent airway obstruction. Vet Immunol Immunopathol 2008;122:256-264.
30. Yang Y, Bin W, Aksoy MO, et al. Regulation of interleukin-1β and interleukin-1β inhibitor release by human epithelial cells. Eur Respir J 2004;23:360-366.
31. Mao XQ, Kawai M, Yamashita T, et al. Imbalance production between interleukin-1β (IL-1β) and IL-1 receptor antagonist (IL-1Ra) in bronchial asthma. Biochem Biophys Res Commun 2000;276:607-612.
32. Kauffman HF. Innate immune responses to environmental allergens. Clin Rev Allergy Immunol 2006;30:129-140.
33. Chaudhuri N, Dower SK, Whyte MK, et al. Toll-like receptors and chronic lung disease. Clin Sci (Lond) [serial online]. 2005;109:125-133.
34. Basu S, Fenton MJ. Toll-like receptors: function and roles in lung disease. Am J Physiol Lung Cell Mol Physiol 2004;286: L887-L892.
35. Sha Q, Truong-Tran AQ, Plitt JR, et al. Activation of airway epithelial cells by toll-like receptor agonist. Am J Respir Cell Mol Biol 2004;31:358-364.
36. Ritter M, Mennerich D, Weigh A, et al. Characterization of Toll-like receptors in primary lung epithelial cells: strong impact of the TLR3 ligand poly(I:C) on the regulation of Toll-like receptors, adaptor proteins and inflammatory response. J Inflamm (Lond) [serial online]. 2005;2:16. Available at: www.journal-inflammation.com/content/2/ 1/16. Accessed March 17, 2007.
37. Armstrong L, Medford AR, Uppington KM, et al. Expression of functional toll-like receptor-2 and -4 on alveolar epithelial cells. Am J Respir Cell Mol Biol 2004;31:241-245.
38. Sabroe I, Whyte MK. Toll-like receptor (TLR)-based networks regulated neutrophilic inflammation in respiratory disease. Biochem Soc Trans 2007;35:1492-1495.